Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F3RUW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,104
Award facts
- Contract value 100% obligated
- $24,103.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Gemtesa 75 mg tablets (90-count units) with a ceiling value of $24,103.99. This firm fixed-price delivery order, which carries an ultimate completion date of December 18, 2025, represents a competitively awarded, non-set-aside contract utilizing AmerisourceBergen's existing federal contract vehicle. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. Gemtesa is a urological medication used to treat overactive bladder, reflecting the breadth of therapeutic categories within the federal medical supply procurement portfolio managed by DLA.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen's demonstrated capability to fulfill federal medical procurement requirements through open competition, combined with its extensive experience distributing specialty medications, brand-name and generic drugs, and medical commodities across multiple therapeutic domains, positions the company as a critical vendor for Defense Health Agency operations and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F3RUW?
SPE2DR26F3RUW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26F3RUW worth?
The government has obligated $24,104 on SPE2DR26F3RUW.
Is contract SPE2DR26F3RUW an order under another contract?
Yes. SPE2DR26F3RUW is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3RUW competed?
The extent of competition for SPE2DR26F3RUW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award